Body fat and cholecalciferol supplementaion in elderly homebound individuals

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 1, 2006, Pages 91-98

  Canto Costa, M H S ^a   Kunii, I ^a   Hauache, Omar M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Body fat content; Cholecalciferol; Obesity; Secondary hyperparathyroidism; Vitamin D insufficiency

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; COLECALCIFEROL; COLLAGEN TYPE 1; OSTEOCALCIN; PARATHYROID HORMONE;

ADIPOSE TISSUE; AGED; ARTICLE; BODY FAT; BODY MASS; BONE REMODELING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG DOSE REGIMEN; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT CONTENT; FEMALE; FRACTURE; GERIATRIC NUTRITION; HORMONE DETERMINATION; HUMAN; MALE; NURSING HOME; PROSPECTIVE STUDY; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 30744444165     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000100011     Document Type: Article

References (27)

1. Riggs L & Melton III LJ (1986). Medical progress: Involutional osteoporosis. New England Journal of Medicine, 314: 1676-1686.
2. Kessenich CR & Rosen CJ (1996). The Pathophysiology of Osteoporosis. In: Rosen CJ (Editor), Osteoporosis - Diagnosis and Therapeutic Principles. Humana Press Inc., Clifton, NJ, USA, 47-63.
3. Need AG, Horowitz M, Morrise HA et al. (2000). Vitamin D status: Effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women. American Journal of Clinical Nutrition, 71: 1577-1581.
4. Harris SS, Soteriades E, Coolidge JA et al. (2000). Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. Journal of Clinical Endocrinology and Metabolism, 85: 4125-4130.
5. Corless D, Beer M, Boucher BJ et al. (1975). Vitamin D status in long-stay geriatric patients. Lancet, 1: 1404-1406.
6. Bell NH, Epstein S, Greene A et al. (1985). Evidence for alteration of the vitamin D-endocrine system in obese subjects. Journal of Clinical Investigation, 76: 370-373.
7. Liel Y, Ulmer E, Shary J et al. (1988). Low circulating vitamin D in obesity. Calcified Tissue International, 43: 199-201.
8. Bell NH, Shaw S & Turner RT (1984). Evidence that 1,25-dihydroxy-vitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. Journal of Clinical Investigation, 74: 1540-1544.
9. Compston JE, Vedi S, Ledger JE et al. (1981). Vitamin D status and bone histomorphometry in gross obesity. American Journal of Clinical Nutrition, 34: 2359-2363.
10. Mawer EB, Backhouse J, Holman CA et al. (1972). The distribution and storage of vitamin D and its metabolites in human tissues. Clinical Science, 43: 414-431.
11. Worstman J, Matsuoka LY, Chen TC et al. (2000). Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition, 72: 690-693.
12. Bischoff-Ferrari HA, Dietrich T, Orav EJ et al. (2004). Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. American Journal of Medicine, 116: 634-639.
13. Chapuy MC, Arlot ME, Delmas PD et al. (1994). Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. British Medical Journal, 308: 1081-1082.
14. Lips P, Graafmans WC, Ooms ME et al. (1994). The effect of vitamin D supplementation on the incidence of hip fractures in elderly people. Journal of Bone and Mineral Research, 9 (Suppl 1): 112 (Abstract).
15. Zittermann A (2003). Vitamin D in preventive medicine: are we ignoring the evidence? British Journal of Nutrition, 89: 552-572.
16. Kartz BS, Jackson GJ, Hollis BW et al. (1993). Diagnostic criterion of vitamin D deficiency. Endocrinologist 3: 248-253.
17. Barger-Lux MJ, Heaney RP, Dowell S et al. (1998). Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporosis International, 8: 222-230.
18. Jacques PF, Felson DT, Tucker KL et al. (1997). Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. American Journal of Clinical Nutrition, 66: 929-936.
19. Parikh JS, Edelman M, Uwaifo GI et al. (2004). The relationship between obesity and serum 1,25 dihydroxy vitamin D concentrations in healthy adults. Journal of Clinical Endocrinology and Metabolism, 89: 1196-1199.
20. Arunabh S, Pollack S, Yeh J et al. (2003). Body fat content and 25-hydroxyvitamin D levels in healthy women. Journal of Clinical Endocrinology and Metabolism, 88: 157-161.
21. Scragg R, Holdaway I, Singh V et al. (1995). Serum 25 hydroxyvitamin D3 is related to physical activity and ethnicity but not to obesity in a multicultural workforce. Australian and New Zealand Medical Journal, 25: 218-223.
22. Ooms ME, Ross JC, Bezemer PD et al. (1995). Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. Journal of Clinical Endocrinology and Metabolism, 80: 1052-1058.
23. Chapuy MC, Arlot ME & Duboeuf F (1992). Vitamin D3 and calcium to prevent hip fractures in elderly women. New England Journal of Medicine, 327: 1637-1642.
24. Vieth R (1999). Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. American Journal of Clinical Nutrition, 69: 842-856.
25. Lips P, Graafmans WC, Ooms ME et al. (1996). Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Annals of Internal Medicine, 124: 400-406.
26. Francis RM, Boyle IT, Moniz C et al. (1996). A comparison of the effects of alphacalcidiol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures. Osteoporosis International, 6: 284-290.
27. Sorva A, Ristell J, Risteli L et al. (1991). Effect of vitamin D and calcium on markers of bone metabolism in geriatric patient with low serum 26-hydroxyvitamin D levels. Calcified Tissue International, 49 (Suppl): S88-S89.